Advancing Oncology Drug Development in the US: The Interplay between Innovations and Regulatory Science
Crossref DOI link: https://doi.org/10.1007/s43441-025-00800-3
Published Online: 2025-05-22
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dou, Yannan Nancy
Wang, Jian
Text and Data Mining valid from 2025-05-22
Version of Record valid from 2025-05-22
Article History
Received: 11 September 2024
Accepted: 7 May 2025
First Online: 22 May 2025
Declarations
:
: The authors declare no competing interests.